GSK-3β inhibitor 12
Modify Date: 2024-04-03 19:21:25
GSK-3β inhibitor 12 structure
|
Common Name | GSK-3β inhibitor 12 | ||
|---|---|---|---|---|
| CAS Number | 784170-07-6 | Molecular Weight | 271.34 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H13N3OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK-3β inhibitor 12GSK-3β inhibitor 12 (compound 15) is an inhibitor of GSK-3β. GSK-3β inhibitor 12 inhibits 49.11% and 37.11% activity of 25 μM and 50 μM GSK-3β, respectively. GSK-3β inhibitor 12 can be used for the research of neurodegenerative diseases[1]. |
| Name | GSK-3β inhibitor 12 |
|---|
| Description | GSK-3β inhibitor 12 (compound 15) is an inhibitor of GSK-3β. GSK-3β inhibitor 12 inhibits 49.11% and 37.11% activity of 25 μM and 50 μM GSK-3β, respectively. GSK-3β inhibitor 12 can be used for the research of neurodegenerative diseases[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Martinez Gil A, et al. N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors. EP20060380099. 2007 |
| Molecular Formula | C14H13N3OS |
|---|---|
| Molecular Weight | 271.34 |